SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-17-170744
Filing Date
2017-05-15
Accepted
2017-05-15 16:48:33
Documents
2
Group Members
PARADIGM VENTURE PARTNERS, L.P.REDMONT VAXN CAPITAL HOLDINGS, LLCREDMONT VENTURE PARTNERS, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D d375869dsc13d.htm SC 13D 81484
2 EX-99.1 d375869dex991.htm EX-99.1 5600
  Complete submission text file 0001193125-17-170744.txt   88628
Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Subject) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-80900 | Film No.: 17845121
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19 FIRSTFIELD RD., SUITE 200 GAITHERSBURG MD 20878
Business Address
Hodges Philip (Filed by) CIK: 0001705562 (see all company filings)

Type: SC 13D